TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | -6 | 0 | -17 | -24 | -63 | -22 |
| P | %wins | 0 | 0 | 100 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/22 09:00 | 3/8/22 | DMRC | Digimarc Corp | OR | Tech | Softw | Computer Integrated Systems D | McCormack Riley | OR | DOT | P,CEO | P.m | 732 | 24.42 | 0 | 30 | 1 | 3,785 | D | ||||||||||||||
2/4/14 11:24 | 2/4/14 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McCormack Riley | FL | T | P.d | 1,700 | 1.70 | 1 | 1,000 | 50 | 3,000 | I | -68 | -52 | 34 | 38 | 24 | -7 | -14 | -5 | -2 | -6 | 0 | -17 | -24 | -63 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |